My watch list  

2,928 Current news from the ressort cooperation


You can refine your search further. Select from the filter options on the left to narrow down your results.

image description
New checkpoint antibody against cancer

BioNTech and OncoC4 announce strategic collaboration


BioNTech SE and OncoC4, Inc., a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel biologicals for cancer treatment, announced that they have entered into an exclusive worldwide license and collaboration agreement to develop and commercialize OncoC4’s ...


image description
New organ-on-chip pilot seeks to reduce animal testing in consumer health industry

Cooperation between Bayer, the start-ups esqLABS and Dynamic42, and Placenta Lab of Jena University Hospital


A first-of-its-kind collaboration in the consumer health industry is developing a platform aimed at reducing or replacing animal testing using “organ-on-chip” (OoC) technology and interactive computational software. The pilot project, supported by esqLABS, Dynamic42, Placenta Lab of Jena ...


image description
BRAIN Biotech and TransCode Therapeutics join forces to develop a CRISPR-derived technology platform for cancer treatment

Development of a CRISPR-derived technology platform for cancer treatment


BRAIN Biotech AG announced the signing of a joint development agreement (JDA) with TransCode Therapeutics, Inc. The objective of the JDA is to co-develop a platform technology that combines a Class 2 CRISPR nuclease, the cell-killing G-dase E, developed by BRAIN Biotech's Akribion Genomics unit ...


image description
Thermo Fisher Scientific announces collaboration with Celltrio

Unlock fully automated cell line production


Thermo Fisher Scientific and Celltrio, a manufacturer of robotics-based solutions for the life sciences industry, have announced their collaboration to bring a fully automated cell culture system to biotherapeutics customers. The collaboration will integrate the Thermo Scientific Momentum ...


image description
Evotec announces agreement with Janssen to develop immune-based therapies

Strategic partnership in oncology


Evotec SE announced that the Company has entered into a strategic collaboration and licence agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson. The collaboration focuses on the development of first-in-class targeted immune-based therapies for ...


image description
Artificial intelligence to reduce costs and improve efficiency in drug discovery

Chemical.AI and NovAliX reached a milestone in collaboration


Chemcial.AI announces the collaboration with NovAliX -a world-leading Drug Discovery CRO company- has reached a milestone. On January 25, 2021, Chemical.AI announced a strategic cooperation with NovAliX in the field of AI-assisted drug discovery. Over the past two years, ChemAIRS, developed by ...


image description
Bayer to Accelerate Drug Discovery with Google Cloud’s High-Performance Compute Power


Bayer AG and Google Cloud announced a collaboration to drive early drug discovery that will apply Google Cloud’s Tensor Processing Units (TPUs), which are custom-developed accelerators designed to run cutting-edge machine learning models and computationally-intensive workloads, to help accelerate ...


image description
Cipla EU to Invest EUR 15 million in Ethris

Cipla & Ethris partner for the development of mRNA-based therapies


Cipla Limited announced that its wholly owned UK subsidiary, Cipla (EU) Limited has signed definitive agreements for equity investment of EUR 15 million in Ethris GmbH, a global leader in delivering mRNAs directly to the respiratory system including administration by inhalation. The investment ...


image description
Merck Announces Collaboration With Mersana Therapeutics to Develop Novel Immunostimulatory Antibody-Drug Conjugates

Mersana to receive $30 million upfront payment, up to $800 million in development, regulatory and commercial milestones, as well as royalties on net sales


Merck announced a research collaboration and commercial license agreement with Mersana Therapeutics, Inc., Cambridge, Massachusetts, USA to discover novel antibody-drug conjugates (ADCs) leveraging Mersana’s proprietary Immunosynthen STING-agonist ADC platform, directed against up to two targets. ...


image description
DSM and LabTwin enter into cooperation

DSM chooses LabTwin to advance their digitalization strategy in Science & Innovation with the latest voice and AI solutions


Royal DSM N.V. and LabTwin GmbH announce a multi-year license and collaboration agreement. DSM will apply the newly acquired technology in several of their Science & Innovation laboratories globally. Together, we intend to transform how science is performed in research and application labs ...


Page 1 From 293
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE